The Northern Europe territory covers Nordic countries (Denmark, Finland, Iceland, Norway and Sweden), Baltic countries (Estonia, Latvia and Lithuania) and Russia. The headquarter is located in Stockholm. This is where it all started back in 1988. We have throughout the years been able to build an high performing commercial organization with an excellent track record in commercializing niche pharmaceuticals in the territory. We are familiar with the local business requirements and work with high ethical standards.
The Central & Eastern Europe region covers Poland, Czech Republic, Slovakia, Hungary, Romania, Bulgaria, Slovenia, Croatia, Serbia, Bosnia & Herzegovina, Macedonia, Montenegro and Kosovo (population CEE total 110 mil). These countries can be divided into two groups one of which comprises EU member states and the other one the countries outside the union. More than 80% of potential comes from the EU members and are considered as core markets. With respect to the differences in languages and healthcare systems, it is extremely important to have local presence and local knowledge of the environment. We have small but right and motivated team and excellence in market access including close cooperation with all stakeholders along with superior internal processes bringing support to local M&S organizations in the field and flexibility towards the changes in outside environment.
The Western Europe region covers the Big 5 countries (Germany, France, Great Britain, Spain and Italy) as well as Belgium, the Netherlands, Switzerland, Austria and Portugal. We have throughout the last couple years been expanding our commercial presence and at the same time improved our commercial capabilities. We have today a committed commercial organization with good experience and track record to work with orphan and niche pharmaceuticals in the territory. We are familiar with the local business requirements and work with high ethical standards.
Sobi a member of the Swedish pharmaceutical industry trade association LIF, guaranteeing high ethics in our operations and at the same time contributing to improved health and quality of life for patients.LIF